NRC Health Reports Record $152M Total Recurring Contract Value, Up 13% Year-Over-Year
Summary
National Research Corporation announced its Total Recurring Contract Value (TRCV) has reached an all-time high of $152 million, reflecting strong growth and customer confidence.
Key Events
-
Record Contract Value Achieved
National Research Corporation announced its Total Recurring Contract Value (TRCV) has reached an all-time high of $152 million as of March 4, 2026.
-
Significant Growth in Recurring Revenue Metric
The TRCV increased by 6% from the end of 2025 and showed a substantial 13% year-over-year growth, highlighting strong business expansion.
-
CEO Highlights Customer Confidence
CEO Trent Green noted that this milestone reflects the confidence of health system partners and the continued expansion of long-term relationships, underscoring the value of NRC Health's platform.
Analysis
This 8-K filing officially discloses a significant operational milestone for NRC Health, with its Total Recurring Contract Value (TRCV) surpassing $152 million. This represents a robust 13% year-over-year increase and a 6% rise since the end of 2025, indicating strong business momentum and expanding long-term customer relationships. The TRCV is a key indicator of future revenue and the health of the company's recurring business model, suggesting continued stability and growth in its healthcare experience improvement solutions.
At the time of this filing, NRC was trading at $13.14 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $297.3M. The 52-week trading range was $9.76 to $22.79. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.